Previous 10 | Next 10 |
Biocept, Inc. (Nasdaq: BIOC), a leading provider of molecular diagnostic assays, products, and services, announces the signing of a non-exclusive licensing agreement for CNSide™ with Plus Therapeutics, Inc. (Nasdaq: PSTV) (Plus), which expands the comprehensive laboratory services agreem...
Biocept, Inc. (Nasdaq: BIOC) (“Biocept” or the “Company”), a leading provider of molecular diagnostic assays, products and services, announces that management will participate in the H.C. Wainwright 25 th Annual Global Investment Conference being held September 1...
2023-08-30 20:38:10 ET Biocept, Inc. (BIOC) Business Update Conference Call August 30, 2023 4:00 PM ET Company Participants Jody Cain - LHA Antonino Morales - President, CEO Dr. Barbara Blouw - VP, Clinical Development Dr. Seema Nagpal - Clinical Professor of...
Biocept, Inc. (Nasdaq: BIOC) management will hold a conference call on August 30, 2023, beginning at 4:00 p.m. Eastern time (1:00 p.m. Pacific time) to provide a business update and to answer questions. Participants can pre-register for the conference call here . Callers who pre-registe...
2023-08-14 17:12:16 ET Biocept press release ( NASDAQ: BIOC ): Q2 GAAP EPS of -$3.50. Revenue of $0.59M (-89.9% Y/Y) misses by $1.06M . Shares +7.27% AH. For further details see: Biocept GAAP EPS of -$3.50, revenue of $0.59M misses by $1.06M
Biocept, Inc. (Nasdaq: BIOC), a leading provider of molecular diagnostic assays, products and services, reports financial results for the three and six months ended June 30, 2023 and provides a business update. “Biocept’s primary focus is establishing our proprietary cerebrosp...
Biocept, Inc . (Nasdaq: BIOC) (“Biocept” or the “Company”), a leading provider of molecular diagnostic assays, products and services, announces that its CNSide cerebrospinal fluid assay was featured in two oral presentations at the 2023 SNO/ASCO CNS Cancer Conferen...
Biocept, Inc . (Nasdaq: BIOC) (“Biocept” or the “Company”) announces that M. Faye Wilson, Board Chair, passed away unexpectedly on Monday, July 10. The Board of Directors and staff of Biocept extend their deepest condolences to the Wilson family and express their gra...
2023-06-27 08:40:16 ET American Equity Investment Life ( AEL ) +16% Reinsurance makes $55 per share offer for American Equity Investment. AC Immune ( ACIU ) +15% receives FDA Fast Track designation for Anti-Amyloid-beta active Immunotherapy, ACI-24.060, to Trea...
2023-06-20 16:30:30 ET Biocept ( NASDAQ: BIOC ) on Tuesday said it had named its interim CFO Antonino Morales as its new CEO, effective immediately. Morales will replace Samuel Riccitelli, who has resigned as interim president and CEO. According to BIOC, Morales h...
News, Short Squeeze, Breakout and More Instantly...
2023-10-18 12:14:27 ET DENVER, Colo., Oct. 18, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual midday volume; Treasure Global Inc (NASDAQ: TGL), SeaStar Medical Holding Corp (NASDAQ: ICU), Mainz Biomed NV (NASDAQ...
Biocept, Inc. (Nasdaq: BIOC), a leading provider of molecular diagnostic assays, products and services, announces the full enrollment of 40 subjects with breast or non-small cell lung cancer (NSCLC) who have suspicious or confirmed leptomeningeal metastases (LM) in the feasibility phase of its ...
2023-09-10 08:02:00 ET Why Penny Stocks Could Be a Good Choice for New Investors Penny stocks, typically priced below $5 per share, offer a myriad of advantages for new investors venturing into the world of stock trading. One of the most appealing aspects of trading penny stocks is ...